Division of AIDS
MHRP Collaborator
Peter Kim, M.D., is the Director of the Therapeutics Research Program (TRP) at the Division of AIDS, National Institute of Allergy and Infectious Diseases. In conjunction with the many dedicated scientists in TRP, Dr. Kim oversees a broad portfolio of research grants and contracts to advance diagnostics and therapeutics for HIV, tuberculosis, and other HIV related co-infections. His medical training is in clinical infectious diseases and his primary areas of expertise and interest include clinical HIV and TB drug development and treatment strategies, as well as TB biomarkers and diagnostics. As part of the U.S. NIH research response to the COVID-19 Pandemic, Dr. Kim also leads the ACTIV-2 family of trials, which are dedicated to developing new outpatient, anti-viral treatments for early COVID-19.